Cite
HARVARD Citation
Sigaux, J. et al. (n.d.). FRI0155 Fifty Percent of Patients Who Tapered TNF-Blockers while in Stable Remission Are Able To Maintain A Tapered Regimen at 3 Year: Long Term Follow-Up Extension of The Strass Trial. Annals of the rheumatic diseases. pp. 484-485. [Online].